Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Product sales, net	$ 3,569,374	$ 2,770,204
Cost of products sold	1,368,190	933,148
Gross profit	2,201,184	1,837,056
Selling, general and administrative expenses	3,001,130	1,898,081
Research and development expenses	143,442	10,118
Total operating expenses	3,144,572	1,908,199
Loss from operations	(943,388)	(71,143)
Interest expense	(1,237)
Interest income	302	1,210
Total other expenses, net	(935)	1,210
Loss before provision for income tax and equity in net earnings of equity investments	(944,323)	(69,933)
Provision for income tax	(46,834)
Loss before equity in net earnings of equity investments	(991,157)	(69,933)
Loss in equity investments	(269,726)	(357,701)
Net Loss	(1,260,883)	(427,634)
Net loss attributable to noncontrolling interests	510,824	8,259
Net loss attributable to Milestone Scientific Inc.	$ (750,059)	$ (419,375)
Net loss per share applicable to common stockholders—
Basic	$ (0.03)	$ (0.02)
Diluted	$ (0.03)	$ (0.02)
Weighted average shares outstanding and to be issued—
Basic	22,609,349	21,919,616
Diluted	22,609,349	21,919,616
Milestone Medical Inc. [Member]
Loss in equity investments		$ (450,160)
Milestone Education LLC [Member]
Loss in equity investments		(4,215)
Milestone China [Member]
Loss in equity investments	$ (164,837)	96,674
(Loss) Gain on earnings from China Joint Venture	$ (269,726)	$ 96,674